Throughout the menopause transition, hormones like estrogen and progesterone naturally fluctuate and decline. These hormonal changes, in large part, drive menopause symptoms ranging from hot flashes to mood changes.

That’s where hormone replacement therapy (HRT) comes in. According to The Menopause Society, the leading U.S. authority on menopause, HRT is the most effective intervention for treating vasomotor symptoms (VMS) like hot flashes and night sweats and genitourinary symptoms of menopause (GSM) like vaginal dryness and painful urination. 

However, not all HRT works the same way. Your doctor might typically evaluate vaginal estrogen versus systemic HRT to find the right fit for your body. Read on as we unpack how each of these hormone therapies works, how they compare, and which option is right for you.

‍

Vaginal estrogen and systemic HRT: Key differences

If you’re experiencing early menopause symptoms or postmenopause discomfort, HRT is worth a conversation with your doctor. Once you decide to pursue HRT, your doctor will likely discuss the different options with you. Two of those options are vaginal estrogen and systemic HRT. Here’s a bit about each, including their key differences.

Vaginal estrogen: Local HRT

Typically, when we talk about vaginal estrogen, we’re referring to local HRT. Local HRT simply means delivering hormones directly to a target area rather than to your whole body. Vaginal estrogen typically provides support for vaginal and urinary symptoms, as well as sexual discomfort. These symptoms can include vaginal dryness, recurrent urinary tract infections (UTIs), and painful intercourse (dyspareunia). This treatment is available in multiple delivery methods, including vaginal tablets, rings, creams, and capsules.

More often than not, vaginal estrogen is low-dose by design. Its low dosage helps confine its effects to local tissue. High-dose vaginal estrogen is an exception; it can enter the bloodstream in sufficient amounts to have systemic effects. When it’s intended to have systemic effects, vaginal estrogen is typically delivered via a high-dose vaginal ring.

Systemic HRT: Higher dose and whole body

Systemic HRT, on the other hand, takes a whole-body approach. It delivers hormones to your bloodstream where they can circulate throughout the body and provide wider symptom relief. Systemic HRT has multiple delivery methods, with two of the most common being:

• Oral: After swallowing the tablet or capsule, the medication absorbs through the intestinal wall into your blood. Your blood then carries the medicine through your liver’s initial filter (first-pass metabolism). Because the liver breaks down some of it, oral HRT often comes in higher doses.
• Transdermal (absorbed through the skin): Patches are the most common type. Because they’re applied to the skin, the medication is absorbed directly into the bloodstream. By bypassing the digestive tract and initial liver metabolism, more of the medication reaches circulation.

There are other delivery methods like injections and sprays, but they’re less common. 

Side-by-side comparison

Here’s a quick comparison of vaginal estrogen versus systemic HRT:

‍

Vaginal estrogen vs. systemic HRT: Menopause symptom management 

Treatment effectiveness depends largely on the specific symptoms you’re targeting.

Systemic HRT for VMS

Because systemic HRT has a body-wide effect, it can influence a range of menopause symptoms. But HRT is particularly effective in treating VMS. A meta-analysis published in the Cochrane Database of Systematic Reviews assessed how systemic oral HRT affected hot flash frequency compared with a placebo. On average, participants experienced a 77% reduction in hot flash frequency. Symptom severity also improved significantly compared to placebo. Plus, there was no meaningful difference in side-effect-related dropouts between HRT and placebo groups. 

Vaginal estrogen for GSM

Since it circulates throughout the body, systemic HRT can also treat GSM. But for persistent cases, doctors prescribe local vaginal estrogen in addition to systemic HRT. According to a 2023 review published in JAMA, low-dose vaginal estrogen is linked to subjective improvement in GSM symptom severity of roughly 60–80%. 

Side effects of systemic HRT and vaginal estrogen

Side effect risks depend on the type of treatment and delivery method. Estrogen-only therapy (ET) and combined estrogen-progesterone therapy (EPT) affect the body differently, carrying distinct risk profiles. 

Systemic HRT side effects

Common side effects of systemic HRT reflect its body-wide reach: 

‍

• Breast tenderness
• Nausea
• Headache
• Unexpected vaginal bleeding or spotting
• Leg cramps

Vaginal estrogen side effects

Vaginal estrogen’s side effects are typically limited to the local area. These include unexpected vaginal bleeding and UTIs. But it’s not out of the ordinary for non-localized side effects to occur, such as headache or breast pain. If your doctor prescribes high-dose vaginal estrogen, you may experience a broader range of non-localized side effects.

‍

‍

Which is safer, vaginal estrogen or systemic HRT?

Both vaginal estrogen and systemic HRT have established conditions that make treatment unsafe (contraindications). Their long-term risk profiles differ significantly due to how they circulate in the body. Vaginal estrogen generally carries a lower risk profile due to its localized delivery; however, neither treatment is entirely risk-free.

Systemic HRT risks

Due to its body-wide impact, the risks of systemic HRT may outweigh those of vaginal estrogen. However, risk is not equal across the forms of systemic HRT. These three examples can shine light on this: 

• Blood clots: When oral HRT passes through the liver, it exposes the liver to a high concentration of estrogen. This prompts liver cells (hepatocytes) to increase the production of certain proteins that cause blood clots, raising the risk of venous thromboembolism (VTE). Transdermal HRT doesn’t carry this same risk because it bypasses the liver.

• Stroke: Oral HRT is associated with a minimal increase in stroke risk, with its effect on blood clotting playing a key role. Low-dose transdermal HRT, mainly due to its route, is not linked to increased stroke risk, though higher doses may carry risk.
• Endometrial cancer: Unopposed estrogen can promote the unusual thickening of the uterine lining, increasing the risk of endometrial cancer. Estrogen-only systemic HRT is the main culprit here. Progesterone helps offset this risk, which is why doctors prescribe combined EPT to women with a uterus.

‍

These risks aren’t cause for alarm. In absolute terms, the overall risk of systemic HRT is low across all forms when prescribed appropriately. It’s safe and effective for many women. You may also be less at risk if you start HRT within 10 years of menopause onset or before age 60. Women within this window of opportunity may have a lower baseline risk of conditions that can be affected by HRT, though baseline risk may increase with age.

Vaginal estrogen risks

Vaginal estrogen’s localized nature may reduce its risk. One study followed 53,000 postmenopausal women over 30 years (1982–2012), excluding any using systemic HRT. Across all conditions tracked by researchers, vaginal estrogen use showed no significant increase in risk. This included cardiovascular disease, cancer, and hip fracture. 

Because of its confined nature, low-dose local vaginal estrogen may not carry the risk of endometrial cancer. However, high-dose vaginal estrogen might because of its systemic effects.

‍

When does combining vaginal estrogen and systemic HRT make sense?

Combining both treatments may be appropriate if systemic HRT relieves some symptoms, but GSM persist. In this situation, it’s common for doctors to prescribe vaginal estrogen alongside systemic HRT to specifically target those remaining symptoms. 

Because these treatments work in different ways and target different areas of the body, combining them is considered safe. Systemic HRT travels through the bloodstream, while low-dose vaginal estrogen impacts the local tissues. Low-dose vaginal treatments don’t significantly raise systemic hormone levels or add to safety risks. Together, both treatments might offer more complete symptom relief. 

‍

Personalized support for your menopause journey

Menopause can take a toll on the body and mind, in unexpected ways. It’s a chapter no one prepares you for. As specialists in women’s care, our clinicians at Maven Clinic can walk by your side. We build hormone care plans around what’s actually going on in your body to treat your symptoms at the root.

Discover our approach to hormone care. 

‍

‍